HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Visual Rating of Posterior Atrophy as a Marker of Progression to Dementia in Mild Cognitive Impairment Patients.

AbstractBACKGROUND:
Although medial temporal atrophy (MTA) is a useful imaging marker of the progression to dementia in mild cognitive impairment (MCI), substantial numbers of MCI patients without MTA still progress to dementia.
OBJECTIVE:
We investigated whether visual ratings of posterior atrophy (PA) on magnetic resonance imaging show independent predictive value for the progression to dementia in MCI patients.
METHODS:
This was a retrospective cohort study of elderly patients who visited Seoul National University Bundang Hospital between 2004 and 2012. A total of 148 patients who were initially diagnosed with MCI were followed for up to 3 years (median 22 months) to determine whether they progressed to dementia. We used 4-point and 5-point visual rating scales to assess PA and MTA, respectively. PA and MTA scores were dichotomized into normal (no atrophy) or abnormal (atrophy) in each patient. We performed a Cox regression analysis to examine the hazard ratios (HRs) of PA and MTA for the progression to dementia with adjustment for age, APOEɛ4 allele status, and baseline Mini-Mental State Examination score.
RESULTS:
Among the study population, 47 patients progressed to dementia. Visual assessment of the MRI scans revealed that 67 patients (45.3%) showed PA, whereas 85 patients (57.3%) showed MTA. The HRs with 95% confidence intervals for PA and MTA were 2.516 (1.244-5.091) and 4.238 (1.680-10.687), respectively. The predictive values of visually assessed PA and MTA remained significant, independent of the covariates.
CONCLUSION:
Visual assessment of PA has independent predictive value for progression to dementia in MCI patients.
AuthorsHang-Rai Kim, Young Ho Park, Jae-Won Jang, So Young Park, Min Jeong Wang, Min Jae Baek, Beom Joon Kim, Soyeon Ahn, SangYun Kim
JournalJournal of Alzheimer's disease : JAD (J Alzheimers Dis) Vol. 55 Issue 1 Pg. 137-146 ( 2017) ISSN: 1875-8908 [Electronic] Netherlands
PMID27636842 (Publication Type: Journal Article)
Chemical References
  • Apolipoprotein E4
Topics
  • Age Factors
  • Aged
  • Aged, 80 and over
  • Apolipoprotein E4 (genetics)
  • Atrophy
  • Brain (diagnostic imaging)
  • Cognitive Dysfunction (diagnostic imaging, genetics, physiopathology)
  • Dementia (diagnostic imaging, genetics, physiopathology)
  • Disease Progression
  • Female
  • Follow-Up Studies
  • Humans
  • Magnetic Resonance Imaging
  • Male
  • Mental Status and Dementia Tests
  • Middle Aged
  • Proportional Hazards Models
  • Retrospective Studies

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: